Cancer Mortality
Bilateral salpingo-oophorectomy reduces overall, but not cancer-specific, mortality
Published in Women's Health Weekly, May 15th, 2006
"Bilateral prophylactic salpingo-oophorectomy (BPSO) is used widely used to reduce the risk of breast and ovarian cancer in women with BRCA1 and BRCA2 mutations. However, the reduction in mortality after this surgery is unclear," noted scientists in the United States.
S.M. Domchek and colleagues of the University of Pennsylvania stated, "We aimed to assess whether BPSO improves overall mortality or cancer-specific mortality in BRCA1 and BRCA2 mutation carriers. We identified a prospective cohort of 666 women with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Lower breast cancer progression from benign breast disease may be linked to aspirin use - Familial Obesity
Weight gain prevention program proves effective in high-risk women with familial obesity - Osteoporosis
Bone fracture incidence is increased in women with pollen-allergy and is related to obesity - Osteoporosis
Osteoporosis risk may be identifiable through dental panoramic radiographs - Allergy & Immunology
Childhood food allergies may be influenced by maternal fish consumption during pregnancy - Angiology
Researchers from Japan, Netherlands and the United States report recent findings in angiology - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
